A Phase I Study of TQ-B3139 on Tolerance and Pharmacokinetics
Clinical trial NCT03099330 · UNKNOWN
Trial details
- NCT number
- NCT03099330
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-19
- Primary completion
- 2018-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.